Collegium Pharmaceutical (NASDAQ: COLL) has recently received a number of price target changes and ratings updates: 12/8/2025 – Collegium Pharmaceutical is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $58.00 price target on the stock. 12/8/2025 – Collegium Pharmaceutical was upgraded by analysts at Weiss Ratings from a “hold […]

Several brokerages have updated their recommendations and price targets on shares of Viemed Healthcare (NASDAQ: VMD) in the last few weeks: 11/25/2025 – Viemed Healthcare had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Viemed Healthcare had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/15/2025 – Viemed Healthcare […]

Several analysts have recently updated their ratings and price targets for Avadel Pharmaceuticals (NASDAQ: AVDL): 11/24/2025 – Avadel Pharmaceuticals had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings. 11/20/2025 – Avadel Pharmaceuticals had its price target raised by analysts at Wells Fargo & Company from $20.00 to $22.50. They now have an “equal […]